HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Dravniece, G. Articles by Zaleskis, R. PubMed PubMed Citation Articles by Dravniece, G. Articles by Zaleskis, R.

Adjunctive resectional lung surgery for extensively drug-resistant tuberculosis

¹ Latvia State Agency of Tuberculosis and Lung Diseases, Riga, Latvia. ² Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USA. ³ World Health Organization, European Regional Office, Copenhagen, Denmark.

CORRESPONDENCE: G. Dravniece, State Agency of Tuberculosis and Lung Diseases p/o Cekule, Stopini, Riga District, Latvia, LV2118. E-mail: gdravniece{at}tuberculosis.lv

Keywords: Epidemiology, extensively drug-resistant tuberculosis, mortality, multidrug-resistant, surgery, tuberculosis

Received: March 26, 2008
Accepted January 6, 2009

Extensively drug-resistant (XDR) tuberculosis (TB) poses significant management challenges as there are limited pharmacological treatment options for cure. Adjunctive resectional lung surgery decreases case-fatality rates for some patients with multidrug-resistant tuberculosis (MDR-TB), but its use has not been well documented for patients with XDR-TB.

We describe 17 XDR-TB patients treated with surgery as part of their case management in Latvia during 1999–2005. One patient had no previous TB treatment history, 10 were previously treated for drug-susceptible TB and six were previously treated for MDR-TB. Mycobacterium tuberculosis isolates from the 17 patients were resistant to a mean of 9.2 drugs. Due to failure of pharmacological therapy, one due to a large cavity and one due to pulmonary haemorrhage, 15 patients were treated with surgery. Despite failure of pharmacological treatment in 15 out of 17 patients, eight (47%) were cured with adjunctive surgical treatment. Surgery should be explored as a possible treatment option for patients with XDR-TB.